Chongqing Pharscin Pharmaceutical Co., Ltd.

Shenzhen Stock Exchange 002907.SZ

Chongqing Pharscin Pharmaceutical Co., Ltd. Free Cash Flow Yield on January 27, 2025: 2.52%

Chongqing Pharscin Pharmaceutical Co., Ltd. Free Cash Flow Yield is 2.52% on January 27, 2025, a 16.83% change year over year. Free cash flow yield compares the return from free cash flow to the market cap; higher yield suggests attractive investment.
  • Chongqing Pharscin Pharmaceutical Co., Ltd. 52-week high Free Cash Flow Yield is 2.92% on February 05, 2024, which is 15.75% above the current Free Cash Flow Yield.
  • Chongqing Pharscin Pharmaceutical Co., Ltd. 52-week low Free Cash Flow Yield is 1.97% on May 14, 2024, which is -21.83% below the current Free Cash Flow Yield.
  • Chongqing Pharscin Pharmaceutical Co., Ltd. average Free Cash Flow Yield for the last 52 weeks is 2.33%.
Key data
Date Free Cash Flow Yield Market Value Added (MVA) Price to Book Ratio (P/B) Price to Earnings Ratio (P/E)
Market news
SV Wall Street
Shenzhen Stock Exchange: 002907.SZ

Chongqing Pharscin Pharmaceutical Co., Ltd.

CEO Ms. Xiaoying Liu
IPO Date Oct. 20, 2017
Location China
Headquarters No. 89, Middle Sec of Huangshan Ave
Employees 1,411
Sector Healthcare
Industries
Pharmaceuticals Biotechnology Cosmetics Drugstores & Retail Pharmacies
Description

Chongqing Pharscin Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of drugs in China. The company offers tablets, powders, granules, hard capsules, soft capsules, powder injections, freeze-dried powder injections, small volume injections, and API synthesis. It provides its products in the areas of CNS, digestion, otolaryngology, oncology, cardiovascular, and cerebrovascular related diseases. Chongqing Pharscin Pharmaceutical Co., Ltd. was founded in 1996 and is headquartered in Chongqing, China.

StockViz Staff

February 3, 2025

Any question? Send us an email